Welcome to our dedicated page for Skinhealth Systems SEC filings (Ticker: SKIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Beauty Health Company (NASDAQ: SKIN) files a range of documents with the U.S. Securities and Exchange Commission that shed light on its operations as a medtech meets beauty business in skin health and aesthetics. This page aggregates those SEC filings and pairs them with AI-powered summaries to help readers interpret the information more efficiently.
Investors can use this resource to access current reports on Form 8-K, where BeautyHealth discloses material events such as quarterly financial results, leadership transitions, board appointments, debt and indenture changes, and amendments to its certificate of incorporation. For example, recent 8-K filings discuss the appointment of a new President and Chief Executive Officer, the appointment of a new independent director, a supplemental indenture related to 7.95% convertible senior notes due 2028, and a certificate of correction to its charter.
In addition to 8-Ks, the company’s annual reports on Form 10-K and quarterly reports on Form 10-Q (when available in the feed) provide detail on net sales, gross margin, adjusted EBITDA, delivery systems sold, active install base, regional performance, risk factors, and capital structure. These filings outline how BeautyHealth combines delivery systems and consumables in its revenue model and how it reports non-GAAP measures alongside GAAP results.
This page also offers easy access to insider and equity-related filings, such as Forms 3, 4, and 5 when they are filed, which can show transactions by directors and officers, as well as proxy and governance documents that describe director compensation, board structure, and key agreements. AI-generated explanations help clarify complex sections, highlight important changes, and point out items that may matter most to shareholders, analysts, and anyone researching SKIN’s regulatory history.
SkinHealth Systems Inc. director Edward Scott Beattie filed an initial Form 3, which is a statement of beneficial ownership required when someone becomes an insider. The filing shows no reported transactions, no derivative positions, and no listed holdings at this time.
SkinHealth Systems Inc. director Edward Scott Beattie filed an initial Form 3, which is a statement of beneficial ownership required when someone becomes an insider. The filing shows no reported transactions, no derivative positions, and no listed holdings at this time.
SkinHealth Systems Inc. director Sachin Mahavir Shridharani filed an initial Form 3 reporting his equity position in the company. The filing shows a direct holding of 1,500 shares of Class A Common Stock. This is a disclosure of existing ownership rather than a new buy or sell transaction.
SkinHealth Systems Inc. director Sachin Mahavir Shridharani filed an initial Form 3 reporting his equity position in the company. The filing shows a direct holding of 1,500 shares of Class A Common Stock. This is a disclosure of existing ownership rather than a new buy or sell transaction.
SkinHealth Systems Inc. reported that Kenneth Robert Tripp has become a reporting person as a director of the company. This Form 3 shows no reported transactions or holdings at this time, serving as an initial ownership statement now that he is subject to insider reporting rules.
SkinHealth Systems Inc. reported that Kenneth Robert Tripp has become a reporting person as a director of the company. This Form 3 shows no reported transactions or holdings at this time, serving as an initial ownership statement now that he is subject to insider reporting rules.
SkinHealth Systems Inc., formerly The Beauty Health Company, has changed its corporate name and updated its charter and bylaws to reflect a strategic focus on clinically driven, science‑backed medical aesthetics. The company will continue trading on the Nasdaq Capital Market under the ticker “SKIN.”
The Board appointed three new independent directors effective April 17, 2026: operations executive Kenneth Tripp, aesthetic medicine expert Dr. Sachin Shridharani, and global beauty and consumer brands leader E. Scott Beattie. The Board temporarily expands to 11 members and is expected to return to 9 following the 2026 annual meeting when two current directors depart.
The company highlights Hydrafacial as its flagship brand and notes an installed base of more than 36,000 devices worldwide, supported by a device‑plus‑consumables model and commercial infrastructure across North America, Europe, and Asia‑Pacific.
SkinHealth Systems Inc., formerly The Beauty Health Company, has changed its corporate name and updated its charter and bylaws to reflect a strategic focus on clinically driven, science‑backed medical aesthetics. The company will continue trading on the Nasdaq Capital Market under the ticker “SKIN.”
The Board appointed three new independent directors effective April 17, 2026: operations executive Kenneth Tripp, aesthetic medicine expert Dr. Sachin Shridharani, and global beauty and consumer brands leader E. Scott Beattie. The Board temporarily expands to 11 members and is expected to return to 9 following the 2026 annual meeting when two current directors depart.
The company highlights Hydrafacial as its flagship brand and notes an installed base of more than 36,000 devices worldwide, supported by a device‑plus‑consumables model and commercial infrastructure across North America, Europe, and Asia‑Pacific.
Millennium Management and affiliated entities reported beneficial ownership of 6,509,750 shares of The Beauty Health Company Class A common stock, representing 5.1% of the class. The filing is a joint Schedule 13G dated 04/17/2026 and states these shares are held by entities subject to voting control and investment discretion by Millennium Management LLC and related managers.
Beauty Health Co executive Sheri Lewis, the CSO and COO, reported a tax-related share disposition. On April 9, 2026, 24,904 shares of Class A common stock, valued at $0.92 per share, were withheld by the company to cover taxes on vesting restricted stock units.
After this withholding, Lewis directly holds 1,584,620 shares of Class A common stock. A footnote clarifies that this was solely to satisfy tax withholding requirements and does not represent an open-market sale of shares.
Beauty Health Co Chief Financial Officer Michael P. Monahan had 26,776 shares of Class A Common Stock withheld by the company to cover tax obligations on vested restricted stock units. The shares were valued at $0.92 per share for this tax-withholding transaction.
After this non-market disposition, which the company states does not represent a sale, Monahan directly holds 1,987,637 shares of Beauty Health Co Class A Common Stock.
Malha Pedro Bruno Ferreira reported acquisition or exercise transactions in this Form 4 filing.
Beauty Health Co reported that President and CEO Pedro Bruno Ferreira Malha received a grant of 2,654,867 restricted stock units (RSUs) of Class A Common Stock as equity compensation. Each RSU represents one share of stock and vests in three equal annual installments starting on the first anniversary of the March 20, 2026 grant date, subject to continued service and certain acceleration rights.
After this award, Malha is shown as beneficially owning 4,845,251 shares of Class A Common Stock directly. The transaction was recorded at a price of $0.00 per share, reflecting that it is a compensation grant rather than an open-market purchase.